Medical News

RSS

Discovery paves way for new therapeutic approaches to treat fatal leukemia in children

Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children. It can occur in various forms, differing not only by specific changes in the genetic material of the leukemia cells but also by their response to therapies.

30 Jul 2015

TGen scientist named a recipient of 2015 Bisgrove Scholars award

Dr. Candace Lewis, a research scientist at the Translational Genomics Research Institute, is one of five recipients of the 2015 Bisgrove Scholars award, Science Foundation Arizona announced today.

30 Jul 2015

Natural protein fragment produced in the brain can inhibit enzyme implicated in Alzheimer's disease

For the first time, UCLA researchers have shown that a natural protein fragment produced in the brain can act as an inhibitor of a key enzyme implicated in the onset of Alzheimer's disease, a finding that could lead to the development of new drugs to treat the disease.

30 Jul 2015

Researchers uncover groundbreaking evidence for developing vaccine to prevent middle ear infections

Researchers from Griffith University's Institute for Glycomics, together with the Nationwide Children's Hospital in Ohio, have uncovered groundbreaking evidence to help vaccine developers prevent middle ear infections.

30 Jul 2015

Cepheid announces international availability of updated Xpert Carba-R test to identify Superbugs

Cepheid today announced the international availability of an update to Xpert Carba-R, with the addition of two newly emerging carbapenemase genes, OXA-181 and OXA-232. The on-demand, molecular test also detects and differentiates among the five most prevalent mechanisms of carbapenem resistance, namely KPC, NDM, VIM, IMP-1 and OXA-48.

29 Jul 2015

Aeterna Zentaris selects optimized Erk inhibitor molecule for further development

Aeterna Zentaris Inc. today announced it has selected an optimized Erk inhibitor molecule for development, thus achieving another important milestone in the development of a new class of potential cancer therapies.

29 Jul 2015

Mice without specific brain chemical develop characteristics similar to bipolar disorder, shows study

Mice that have a particular brain chemical switched off become hyperactive and sleep for just 65 per cent of their normal time.

29 Jul 2015

Prior Scientific launches new Lumen 200S metal halide illumination system with shutter control

Prior Scientific, a leading supplier of illumination equipment for fluorescence microscopy, announces the new Lumen 200S metal halide illumination system with shutter control.

From Prior Scientific Instruments Ltd. 29 Jul 2015

World Health Organization recognizes unique pharmacological nature of Can-Fite's CF101, grants new generic name

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced that the World Health Organization's International Nonproprietary Name group has accepted the proposed generic name "piclidenoson" for its lead drug candidate, CF101.

29 Jul 2015

LixiLan-O Phase III clinical trial meets primary endpoint in patients with type 2 diabetes

Sanofi announced today that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin. The fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide, a GLP-1 RA, demonstrated statistically superior reduction in HbA1c (average blood glucose over the previous three months) compared with lixisenatide and compared with insulin glargine 100 units/mL.

29 Jul 2015

GE Healthcare to invest more than $1 billion over five years in enhanced training for healthcare professionals

In developed countries like the U.S., Europe and parts of Asia, healthcare leaders are trying to optimize efficiency, systems integration, data analytics and achieve greater productivity. In emerging economies, enabling access to affordable, basic primary care is often the most pressing concern. Healthcare systems around the world face a wide range of difficult challenges. All could benefit from training and education solutions focused specifically on their particular needs.

29 Jul 2015

RepliCel Life Sciences announces final design specifications for next-generation dermal injector

RepliCel Life Sciences Inc., a clinical stage regenerative medicine company, is pleased to announce that the final design specifications of its next-generation dermal injector (RCI-02) have been locked. Prototypes for industrial and regulatory testing will now be built to prepare for an application for CE mark clearance to market the injector in Europe in 2016.

29 Jul 2015

PDL BioPharma signs revenue interest assignment agreement with ARIAD Pharmaceuticals

PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).

29 Jul 2015

Mylan receives regulatory clearance from European Commission for proposed acquisition of Perrigo

Mylan N.V. today announced that it received regulatory clearance from the European Commission under the European Union Merger Regulation (EUMR) for its proposed acquisition of Perrigo Company plc.

29 Jul 2015

Henry Schein reports net sales of $2.6 billion for second quarter 2015

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record second quarter financial results.

29 Jul 2015

Same brain cells involved in encoding and retrieving memories

Are the same regions and even the same cells of the brain area called hippocampus involved in encoding and retrieving memories or are different areas of this structure engaged? This question has kept neuroscientists busy for a long time. Researchers at the Mercator Research Group "Structure of Memory" at RUB have now found out that the same brain cells exhibit activity in both processes.

29 Jul 2015

Study sheds new light on the brain’s learning capacity

How do you get to Carnegie Hall? New research on the brain's capacity to learn suggests there's more to it than the adage that "practise makes perfect." A music-training study by scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and colleagues in Germany found evidence to distinguish the parts of the brain that account for individual talent from the parts that are activated through training.

29 Jul 2015

$UO-led effort on fractal-based nerve connections granted U.S. patent$

UO-led effort on fractal-based nerve connections granted U.S. patent

Richard Taylor's vision of using artificial fractal-based implants to restore sight to the blind -- part of a far-reaching concept that won an innovation award this year from the White House -- is now covered under a broad U.S. patent.

29 Jul 2015

AAN's Behavioral Neurology Section Group provides recommendations for improving clinical cognitive testing

Recommendations for improving clinical cognitive testing were reported by the American Academy of Neurology's Behavioral Neurology Section Group, led by Kirk R. Daffner, MD, of Boston, Mass. The Group focused on the Neurobehavioral Status Exam (NBSE), conducting evidence-based reviews of testing used for five domains - attention, language, memory, spatial cognition, and executive function).

29 Jul 2015

Study reveals that firms 'underinvest' in long-term research to develop cancer-fighting drugs

Pharmaceutical firms "underinvest" in long-term research to develop new cancer-fighting drugs due to the greater time and cost required to conduct such research, according to a newly published study co-authored by MIT economists.

29 Jul 2015

Medical News

Discovery paves way for new therapeutic approaches to treat fatal leukemia in children

TGen scientist named a recipient of 2015 Bisgrove Scholars award

Natural protein fragment produced in the brain can inhibit enzyme implicated in Alzheimer's disease

Researchers uncover groundbreaking evidence for developing vaccine to prevent middle ear infections

Cepheid announces international availability of updated Xpert Carba-R test to identify Superbugs

Aeterna Zentaris selects optimized Erk inhibitor molecule for further development

Mice without specific brain chemical develop characteristics similar to bipolar disorder, shows study

Prior Scientific launches new Lumen 200S metal halide illumination system with shutter control

World Health Organization recognizes unique pharmacological nature of Can-Fite's CF101, grants new generic name

LixiLan-O Phase III clinical trial meets primary endpoint in patients with type 2 diabetes

GE Healthcare to invest more than $1 billion over five years in enhanced training for healthcare professionals

RepliCel Life Sciences announces final design specifications for next-generation dermal injector

PDL BioPharma signs revenue interest assignment agreement with ARIAD Pharmaceuticals

Mylan receives regulatory clearance from European Commission for proposed acquisition of Perrigo

Henry Schein reports net sales of $2.6 billion for second quarter 2015

Same brain cells involved in encoding and retrieving memories

Study sheds new light on the brain’s learning capacity

UO-led effort on fractal-based nerve connections granted U.S. patent

AAN's Behavioral Neurology Section Group provides recommendations for improving clinical cognitive testing

Study reveals that firms 'underinvest' in long-term research to develop cancer-fighting drugs

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News